Launch of Levamide tablets for anti-inflammatory gastritis and gastric ulcer treatment

 

 

 

KyungDong Pharm launched Levamide tablets, a mucous membrane-protecting gastritis and gastric ulcer treatment containing rebamipide, on July 1.

Levamide tablets are the only products among mucous membrane-protective gastritis and gastric ulcer treatments that simultaneously suppress inflammation and improve the speed and quality of ulcer treatment.

In addition, Levamid tablets are produced using the rebamipid raw material independently developed by KyungDong Pharm Central Research Institute, making it a safer and more reliable product.

 

 

Levamide tablets
● Ingredients/Content
1 politeness
Rebamipide 100mg

●Efficacy/Effectiveness
1. Stomach ulcer
2. Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) of the following diseases: acute gastritis, acute exacerbation of chronic gastritis

●Usage/Dosage
1. Stomach ulcer
Adults usually take 1 tablet 3 times a day, in the morning, evening, and before bedtime.
2. Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) of the following diseases: acute gastritis, acute exacerbation of chronic gastritis
Normally, adults take 1 tablet orally 3 times a day.

●Packing unit
100 tablets, 500 tablets